+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Healthcare Cold Chain Logistics - Global Strategic Business Report

  • PDF Icon

    Report

  • 274 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140964

Global Healthcare Cold Chain Logistics Market to Reach $23.8 Billion by 2030

The global market for Healthcare Cold Chain Logistics estimated at US$18.2 Billion in the year 2023, is projected to reach a revised size of US$23.8 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Vaccines, one of the segments analyzed in the report, is expected to record 3.1% CAGR and reach US$11.1 Billion by the end of the analysis period. Growth in the Clinical Trial Materials segment is estimated at 3.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.8 Billion, While China is Forecast to Grow at 5.2% CAGR

The Healthcare Cold Chain Logistics market in the U.S. is estimated at US$4.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5 Billion by the year 2030 trailing a CAGR of 5.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 2.7% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Report Features

  • Full access to influencer engagement stats
  • Access to digital archives & research platform. The proprietary platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. The state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
  • Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
  • Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
  • Complimentary report updates for one year
  • Competitor coverage with global market shares of major players
  • Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
  • Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 44 Featured) -

  • American Airlines, Inc.
  • AmerisourceBergen Corporation
  • Cavalier Logistics
  • Continental Carbon Company
  • DB Schenker
  • DHL International GmbH
  • FedEx Corporation
  • Kuehne + Nagel International AG
  • Marken Ltd.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Healthcare Cold Chain Logistics - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Healthcare Cold Chain Logistics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World 16-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World 16-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 6: World Recent Past, Current & Future Analysis for Clinical Trial Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 7: World 16-Year Perspective for Clinical Trial Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Biopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World 16-Year Perspective for Biopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World 16-Year Perspective for Transportation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 12: World Recent Past, Current & Future Analysis for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 13: World 16-Year Perspective for Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World 16-Year Perspective for Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 16: World Historic Review for Healthcare Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 17: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 18: World Historic Review for Clinical Trial Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: World Historic Review for Biopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 20: World Historic Review for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 21: World Historic Review for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: World Historic Review for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
III. MARKET ANALYSIS
UNITED STATES
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: USA 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
  • Table 25: USA Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 26: USA 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • Table 27: USA Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: USA Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: Canada 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
  • Table 31: Canada Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 32: Canada 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • Table 33: Canada Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Canada Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
JAPAN
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: Japan 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
  • Table 37: Japan Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 38: Japan 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • Table 39: Japan Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: Japan Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
CHINA
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: China 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
  • Table 43: China Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 44: China 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • Table 45: China Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: China Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
EUROPE
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 48: Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 49: Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 50: Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
  • Table 51: Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 52: Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • Table 53: Europe Historic Review for Healthcare Cold Chain Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 54: Europe Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Europe Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
FRANCE
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: France 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
  • Table 58: France Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 59: France 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • Table 60: France Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: France Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
GERMANY
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
  • Table 64: Germany Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 65: Germany 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • Table 66: Germany Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Germany Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
  • Table 70: Italy Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 71: Italy 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • Table 72: Italy Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: Italy Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
UNITED KINGDOM
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: UK 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
  • Table 76: UK Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 77: UK 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • Table 78: UK Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: UK Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: Spain 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
  • Table 82: Spain Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 83: Spain 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • Table 84: Spain Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: Spain Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Russia 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
  • Table 88: Russia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 89: Russia 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • Table 90: Russia Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: Russia Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
  • Table 94: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 95: Rest of Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • Table 96: Rest of Europe Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 97: Rest of Europe Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
ASIA-PACIFIC
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 99: Asia-Pacific 16-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 100: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 101: Asia-Pacific 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
  • Table 102: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
  • Table 104: Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 106: Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
AUSTRALIA
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • American Airlines, Inc.
  • AmerisourceBergen Corporation
  • Cavalier Logistics
  • Continental Carbon Company
  • DB Schenker
  • DHL International GmbH
  • FedEx Corporation
  • Kuehne + Nagel International AG
  • Marken Ltd.

Table Information